Literature DB >> 15743545

Menstrual migraine.

Ana Recober1, Lynne O Geweke.   

Abstract

Migraine is a common disorder that is disproportionately prevalent in women, especially during the reproductive years. Hormonal changes may play a role in the etiology of migraine, as many women note that their migraine attacks occur in temporal relationship with their menses. The Headache Classification Subcommittee of the International Headache Society has recently defined menstrual and menstrually related migraine. We review the most relevant and recent literature on menstrual migraine, with a special focus on pathophysiology and therapy. Although the pathogenesis of menstrual and menstrually related migraine is not well understood, estrogen withdrawal seems to play an important role as a trigger for menstrual migraine attacks. The therapeutic approach also may differ from the treatment of nonmenstrual migraine. Some patients do not require prophylaxis when they can abort their attacks effectively, whereas others may benefit from perimenstrual prophylaxis or standard migraine prophylaxis.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15743545     DOI: 10.1007/s11910-005-0005-4

Source DB:  PubMed          Journal:  Curr Neurol Neurosci Rep        ISSN: 1528-4042            Impact factor:   5.081


  41 in total

1.  Estrogen-withdrawal migraine. I. Duration of exposure required and attempted prophylaxis by premenstrual estrogen administration.

Authors:  B W Somerville
Journal:  Neurology       Date:  1975-03       Impact factor: 9.910

Review 2.  Prophylaxis of menstrual migraine with triptans: problems and possibilities.

Authors:  Elizabeth Loder
Journal:  Neurology       Date:  2002-12-10       Impact factor: 9.910

3.  The role of estradiol withdrawal in the etiology of menstrual migraine.

Authors:  B W Somerville
Journal:  Neurology       Date:  1972-04       Impact factor: 9.910

4.  Rizatriptan in the treatment of menstrual migraine.

Authors:  S D Silberstein; H Massiou; C Le Jeunne; L Johnson-Pratt; K A McCarroll; C R Lines
Journal:  Obstet Gynecol       Date:  2000-08       Impact factor: 7.661

Review 5.  Hormonal interventions for menstrual migraines.

Authors:  Kathleen J Chavanu; Dannielle C O'Donnell
Journal:  Pharmacotherapy       Date:  2002-11       Impact factor: 4.705

6.  Treatment of menstruation-associated migraine with the nonprescription combination of acetaminophen, aspirin, and caffeine: results from three randomized, placebo-controlled studies.

Authors:  S D Silberstein; J J Armellino; H D Hoffman; J P Battikha; S W Hamelsky; W F Stewart; R B Lipton
Journal:  Clin Ther       Date:  1999-03       Impact factor: 3.393

7.  Continuous bromocriptine therapy in menstrual migraine.

Authors:  A G Herzog
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

8.  A randomized trial of frovatriptan for the intermittent prevention of menstrual migraine.

Authors:  Stephen D Silberstein; Arthur H Elkind; Curtis Schreiber; Charlotte Keywood
Journal:  Neurology       Date:  2004-07-27       Impact factor: 9.910

9.  The association of menstrual migraine with the premenstrual syndrome.

Authors:  F Facchinetti; I Neri; E Martignoni; L Fioroni; G Nappi; A R Genazzani
Journal:  Cephalalgia       Date:  1993-12       Impact factor: 6.292

10.  Medical oophorectomy with and without estrogen add-back therapy in the prevention of migraine headache.

Authors:  Vincent Martin; Suzanne Wernke; Karen Mandell; Willie Zoma; Judy Bean; Susan Pinney; James Liu; Nabih Ramadan; Robert Rebar
Journal:  Headache       Date:  2003-04       Impact factor: 5.887

View more
  3 in total

1.  Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, multicenter, Italian, comparative study versus zolmitriptan.

Authors:  Gianni Allais; Vincenzo Tullo; Chiara Benedetto; Dario Zava; Stefano Omboni; Gennaro Bussone
Journal:  Neurol Sci       Date:  2011-05       Impact factor: 3.307

2.  Efficacy of frovatriptan in the acute treatment of menstrually related migraine: analysis of a double-blind, randomized, cross-over, multicenter, Italian, comparative study versus rizatriptan.

Authors:  Lidia Savi; Stefano Omboni; Carlo Lisotto; Giorgio Zanchin; Michel D Ferrari; Dario Zava; Lorenzo Pinessi
Journal:  J Headache Pain       Date:  2011-08-13       Impact factor: 7.277

Review 3.  Spotlight on frovatriptan: a review of its efficacy in the treatment of migraine.

Authors:  Gianni Allais; Chiara Benedetto
Journal:  Drug Des Devel Ther       Date:  2016-10-03       Impact factor: 4.162

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.